We studied the characteristicsof bindingof cardiac gylcosides to particulate membrane fractions from human placenta, to demonstrate that placental tissue is a suitable source of receptors for digitalis drugs. Moreover, we per- 
immunological methods for assay of digoxin-like immunoreactivity can give some erroneous findings and difficulties in interpretation of results (2, 7) . Specific and nonspecific interferences probably are both present in all digoxin immunoassays, and the ratio between these two forms of interferences probably varies greatly with different immunological methods, and also in the same system when different lots of antiserum are used or the assay procedures (incubation time or temperature) are changed (2, 7) . The non-immunological procedures (radioreceptor assay, measurement of the inhibition of ion transport across the membrane, or of Na/K-ATPase activity) are considered more specific for the measurement of digitalis-like substances, but are generally cumbersome, time consuming, and less sensitive than immunological methods (2, 7) . Recently, a radioreceptor assay has been described for measurement of digoxin in which [3H]digoxin is used as tracer and NaVK-ATPase from autopsied human heart as receptors (8). However, autopsy material is not easily available, and membranes prepared from autopsy tissues may be affected by a general loss of receptors and unpredictable changes of binding properties (9) .
Whitsett and Wallick (10) reported the presence of specific receptors for [3Hlouabain in human placenta. Therefore, we studied the binding characteristics of cardiac glycosides to membrane preparations from human placenta to demonstrate that placental tissue may be a suitable source of digitalis drugs receptors. Moreover, lmIlabeled tracers generally improve the practicability and the sensitivity of RIAs and radioreceptor assays, so we performed preliminary experiments with '251-labeled digoxin and placental particulates, to develop a radioreceptor assay for measurement of endogenous substances with activity similar to that of cardiac glycoside drugs.
Materials and Methods

Preparation of placental membranes.
Particulate membrane fractions from human placenta were prepared as described by Schocken et al. (11) . Term placentas, obtained with consent immediately after delivery, were trimmed free of adherent membranes, minced, and homogenized with a Kinematica GmbH Polytron PT 10-35 in 2.5 volumes of ice-cold homogenization buffer (per liter, 250 mmol of sucrose, 1 mmol of MgC12, and 5 mmol of Tris hydrochloride, pH 7.4, at 4#{176}C) by means of three consecutive 10-s bursts at maximum speed. The homogenates were filtered through two layers of cheesecloth and subjected to differential centrifugation at 4 #{176}C. After centrifugation for 10 mm at 2000 x g, the supernates were centrifuged at 39000 x g for 10 mm. The resulting pellets were resuspended by gentle homogenization at 4#{176}C in 50 mmol/L Tris hydrochloride buffer, pH 7.4, washed, and recentrifuged twice under the same conditions. The final pellets were resuspended in the same buffer at a protein concentration of [8] [9] [10] [11] [12] and 50 pL of 'I-labeled digoxin (0.5 nmol/L; NEN Dii Pont; specific radioactivity 2200 kCilmol) were incubated in polypropylene tubes at 37 #{176}C, with or without 100 L of digoxin solutions (from 10 nmol/L to 10 mol/L) or sample extracts in a total volume of 500 pL of incubation buffer (per liter: 5 mmol of MgCl2, 5 mmol of Na2HPO4, and 50 mmol of Tris hydrochloride, pH 7.4, at 37 #{176}C). After incubation, 400 pL of the incubation mixture was transferred to pre-chilled microtubes and promptly centrifuged in a Beckman Microfuge B for 2.5 mm at 4#{176}C. Membrane pellets were washed with 400 L of 50 mmolJL Tris hydrochloride buffer, pH 7.4, at 4#{176}C and counted in a gamma spectrometer at about 75% efficiency. We chose centrifugation because a large amount of 1251.. labeled digoxin was nonspecifically bound to glass-fiber ifiters, thus obscuring specific receptor binding of the hgand. A 10 mmol/L stock solution of digoxin was prepared in dimethyl sulfoxide, which did not affect the maximal specific binding of '251-labeled digoxin to the membranes. Subsequent dilutions were prepared in incubation buffer. Specific binding of 1251-labeled digoxin was defined as the difference between radioactivity bound in the absence or presence, during incubation, of digoxin, 10 moI/L.
Each binding assay was performed in duplicate and repeated at least three times. Binding data were expressed as mean ± SEM. The values measured by the radioreceptor assay were expressed as digoxin equivalents (nmol per liter of serum or urine). We used a Macintosh SE personal computer to analyze receptor radioligand curves and results. The precision profile of the radioreceptor assay was calculated by previously described computer programs (13, 14) .
Samples. Plasma pools from 44 normal subjects, from six uremic patients, and from more than 50 pregnant women in the first, second, and third trimesters of pregnancy; one pooled specimen of serum from some newborns (cord blood); and two urine pools from some newborns (first or second postnatal day) and from normal adult subjects were pre- Before the analysis, each plasma (serum) or urine sample was extracted on fresh SepPak C18 cartridges (Waters Associates) as previously described (15) . A 2-mL sample was applied to each cartridge that had been previously activated with 4 mL of methanol followed by 20 mL of distilled water. After we washed the resin with 40 mL of distilled water, each cartridge was eluted with 4 mL of methanol.
The extracts were evaporated under reduced pressure, the dry residues were redissolved in 250 zL of incubation buffer, and 100 .L of this solution were then used in the radioreceptor assay. Extraction of urine or plasma (serum) samples with SepPak C18 cartridges avoided interferences from ions (such as K) (15) , proteins, or fatty acids. More than 99.5% of the albumin or total proteins in the sera, and more than 99% of the free fatty acids were eliminated by the washings of the resin. Moreover, even though steroid hormones are surely present in the extracts, we found that progesterone or cortisone, at least, did not significantly inhibit Ilabeled digoxin binding (see Results, Figure 5a ). The extraction procedure, moreover, allowed an eightfold concentration of samples. Specific ouabain binding to human placental membranes was inhibited by a serum extract of umbilical cord blood (Figure 3) . Binding inhibition, up to a concentration of 1 nmol of ouabain per liter, was about 45% (Figure 3) . A change in affinity, rather than in the receptor number, seems to account for the observed change in [3Hlouabain binding. In contrast, plasma extracts from blood donors had no significant effect on the specific binding of [3Hjouabain to human placental membranes (data not shown).
Results
1251-labekd digoxin binding to placental membranes.
The time course of total, specific, and nonspecific binding of '251-labeled digoxin (50 pmoIJL) to human placental particulates (300 .ig/mL) at 37#{176}C and pH 7.4 is shown in Figure  4 . Specific binding reached a plateau (26.5% ± 2.6%) within 4 h and remained constant for 2 h more. Nonspecific binding averaged 4.6% ± 1.0%. The time required to obtain steady-state decreased with increasing 1251-labeled digoxin or protein concentration. manner by ouabain, digoxin, and digoxigenin, one of the cardioactive metabolites of digoxin. As expected, ouabain was more effective than digoxin in inhibiting binding with EC50 values (molar concentration for 50% inhibition) of about 7 nmoliL and 45 nmol/L, respectively. The inhibition constant for 'I-labeled digoxin binding to placental membranes by ouabain was 7.2 ± 1.0 nmol/L. Digoxigernn, which was reported to have a lower cardioactivity than digoxin (18), was unexpectedly found to have the same potency in displacing '25I-labeled digoxin from its binding sites. However, the shape of the displacement curve for the two substances was quite different: the curve for digoxigenm was fiat and, after transformation into a "pseudo Scatchard plot" (19) liter. The mean sensitivity (n = 7) of the assay was 5.7 ± 0.9 nmol/L. Linear relationships with correlation coefficients >0.98 were found between the volumes assayed and the digoxin equivalents measured by the radioreceptor assay in different pooled specimens of plasma (serum) or urine from newborns, adult normal subjects, pregnant women, and uremic patients (data not shown).
Newborns, pregnant women, and uremic patients showed higher values for circulating digitalis-like substances than did normal subjects; moreover, higher values were found for urine of newborns and adult subjects compared with those for plasma ( Table 1) .
Discussion
Our findings confirm that specific receptors for cardiac glycoside drugs are present in human placenta and indicate that this tissue may be a readily available source of NafK-ATPase.
In fact, the putative receptor showed high affinity and saturable binding to [3H]ouabain and 1251-labeled digoxin. The affinity of placental Na'/KATPase for digitalis drugs was similar to that shown by the enzyme isolated from other tissues [e.g., dog kidney, porcine heart, human heart (8), human erythrocytes (20)1, and the maximum number of binding sites was high. As expected, digoxin was less potent than ouabain in displacing tracer from digitalis drugs receptors, whereas digitoxose, progesterone, cortisone, furosemide, buinetanide, and (±)-propranolol had no or little effect.
Multiple sites with high and low affinity for cardiac glycosides have been reported in rat cardiac ventricle (21) and cultured chick heart cells (22) , with [3H]ouabain used as a ligand. The presence of multiple forms of binding sites with different affinity to digitalis drugs may affect the sensitivity and specificity of a radioreceptor assay. However, in the present study both [3Hlouabain and 'Ilabeled digoxin shared only one class of binding sites for cardiac glycosides in the human placenta, thus confirming [3H]ouabain binding data previously reported by Whitsett and Wallick (10), and indicating that human placenta is a suitable tissue for radioreceptor assay of digitalis drugs.
The 1251-labeled digoxin was found to label digitalis drugs receptors of the human placenta with an affinity similar to that shown by [8H]ouabain, but its use enhanced practicability and sensitivity of the radioreceptor assay of digoxin-like immunoreactive substances. A linear relationship was found between the volumes assayed and the digoxin equivalents measured by the '251-labeled digoxin radioreceptor assay in different plasma (serum) or urine pools of newborns, adult normal subjects, pregnant women, and uremic patients. As expected (1,2), pooled specimens of plasma (serum) from newborns, pregnant women, and uremic patients showed higher values for digitalis-like substances in the circulation than did a plasma pool from normal subjects. Moreover, higher values were found for urine of newborns and adult subjects as compared with concentrations inthe circulation. The presence of high-affinity digitalis drugs receptors in human placenta and the high values for endogenous digitalis-like substances in the circulation of mothers and newborns indicate that these endogenous factors may have an important role in the regulation of electrolyte and fluid balance in the feto-placental unit and in the pathogenesis of hypertension and eclampsia in pregnancy, as also suggested by other authors (4) (5) (6) .
